RARRES2 and pancreas disorder: Future research should include longitudinal human studies to determine whether dynamic changes in chemerin levels parallel disease progression or resolution and to clarify whether chemerin acts predominantly as a marker of disease severity or a modulator of protective immune regulation in pancreatic diseases.